FDA policing researchers enough?

Not to be outdone by Democrats calling for pharma-related investigations by the Government Accountability Office, two Republican Congressmen are asking the GAO to probe the FDA's methods for disciplining researchers who break drug-trial rules. Rep. Joe Barton and John Shimkus wrote a letter to the government auditor, saying that FDA oversight of trials needs to be reviewed.

Barton alleged in a statement that the FDA "has waited months and sometimes years to take action against doctors who lied about their work" and suggests that the agency should use its authority to disqualify any "liars" from participating in drug studies. The two men also want the GAO to determine whether the FDA does enough to identify researchers "whose practices or conduct may compromise" trial data.

- see the item at Pharmalot

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.